TOKYO -- Sumitomo Pharma is considering laying off employees in its home market of Japan as early as this fiscal year, new President Toru Kimura told Nikkei, as the loss of U.S. exclusivity rights on the Latuda schizophrenia drug drags down its earnings.
Pharmaceuticals
After U.S. job cuts, Sumitomo Pharma eyes layoffs in Japan
New president stresses downsizing to turn around earnings slump
Toru Kimura, Sumitomo Pharma's new president. (Photo by Arisa Moriyama)
Read Next
Latest on Pharmaceuticals
